{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:55:50Z","timestamp":1794009350152,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573683"],"award-info":[{"award-number":["82573683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404013"],"award-info":[{"award-number":["82404013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8207091375"],"award-info":[{"award-number":["8207091375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Talent of Lifting Engineering for Science and Technology Program of Shandong Province, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Emerging evidence highlights that metabolic reprogramming profoundly shapes the tumor microenvironment and immune evasion in prostate cancer. However, the functional role and mechanisms of tryptophan metabolism in prostate cancer progression remain unclear. Through single-cell transcriptomic analysis, we identified one tumor cell subtype characterized by high expression of 3-hydroxyanthranilate 3,4-dioxygenase (HAAO) and enhanced kynurenine pathway activity. This subpopulation leads to the accumulation of quinolinic acid (QA), a metabolic intermediate that could activate the mevalonate (MVA) pathway. Mechanistically, QA directly binds to and stabilizes farnesyl diphosphate synthase (FDPS), a key MVA pathway enzyme, thereby enhancing cholesterol biosynthesis and fueling androgen receptor (AR)-driven transcriptional programs. This HAAO\/QA-FDPS axis establishes a metabolic crosstalk that links tryptophan catabolism to lipid metabolism, sustaining prostate tumor progression. Furthermore, an integrated prognostic model incorporating this pathway signatures outperforms other clinical variables alone, and HAAO-high tumors exhibit heightened sensitivity to combined inhibition of the kynurenine and AR pathways. Our study unveils a novel metabolic vulnerability in prostate cancer and provides a mechanistic rationale for targeting the HAAO\/QA-FDPS axis for therapy.<\/jats:p>","DOI":"10.1038\/s41420-026-03203-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:34:50Z","timestamp":1781598890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HAAO\u2011derived quinolinic acid fuels FDPS\u2011dependent AR signaling and sensitizes prostate cancer to combination therapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Hongchang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhurui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-0212","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"3203_CR1","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL. Metabolic reprogramming in prostate cancer. Br J Cancer. 2021;125:1185\u201396.","journal-title":"Br J Cancer"},{"key":"3203_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27\u201347.","journal-title":"Cell Metab"},{"key":"3203_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5758","volume":"11","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med. 2019;11:eaau5758.","journal-title":"Sci Transl Med"},{"key":"3203_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/1541-7786.MCR-16-0480","volume":"15","author":"MA White","year":"2017","unstructured":"White MA, Lin C, Rajapakshe K, Dong J, Shi Y, Tsouko E, et al. Glutamine transporters are targets of multiple oncogenic signaling pathways in prostate cancer. Mol Cancer Res. 2017;15:1017\u201328.","journal-title":"Mol Cancer Res"},{"key":"3203_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s43556-025-00321-3","volume":"6","author":"D Cui","year":"2025","unstructured":"Cui D, Yu X, Guan Q, Shen Y, Liao J, Liu Y, et al. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6:72.","journal-title":"Mol Biomed"},{"key":"3203_CR6","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1038\/s41388-025-03573-z","volume":"44","author":"M Chukhu","year":"2025","unstructured":"Chukhu M, Dahiya UR, Heemers HV. Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer. Oncogene. 2025;44:3883\u201394.","journal-title":"Oncogene"},{"key":"3203_CR7","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1038\/onc.2012.6","volume":"31","author":"JW Clendening","year":"2012","unstructured":"Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins. Oncogene. 2012;31:4967\u201378.","journal-title":"Oncogene"},{"key":"3203_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2014.01.013","volume":"356","author":"G Gruenbacher","year":"2015","unstructured":"Gruenbacher G, Thurnher M. Mevalonate metabolism in cancer. Cancer Lett. 2015;356:192\u20136.","journal-title":"Cancer Lett"},{"key":"3203_CR9","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1158\/0008-5472.CAN-11-1821","volume":"71","author":"Q Wang","year":"2011","unstructured":"Wang Q, Bailey CG, Ng C, Tiffen J, Thoeng A, Minhas V, et al. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res. 2011;71:7525\u201336.","journal-title":"Cancer Res"},{"key":"3203_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s43018-024-00820-2","volume":"5","author":"B Dong","year":"2024","unstructured":"Dong B, Xu J-Y, Huang Y, Guo J, Dong Q, Wang Y, et al. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. Nat Cancer. 2024;5:1427\u201347.","journal-title":"Nat Cancer"},{"key":"3203_CR11","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3203_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"key":"3203_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197\u2013203.","journal-title":"Nature"},{"key":"3203_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1021\/acs.jproteome.8b00803","volume":"18","author":"A Khan","year":"2019","unstructured":"Khan A, Choi SA, Na J, Pamungkas AD, Jung KJ, Jee SH, et al. Noninvasive serum metabolomic profiling reveals elevated kynurenine pathway\u2019s metabolites in humans with prostate cancer. J Proteome Res. 2019;18:1532\u201341.","journal-title":"J Proteome Res"},{"key":"3203_CR15","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910\u20134.","journal-title":"Nature"},{"key":"3203_CR16","doi-asserted-by":"crossref","unstructured":"Peng Y, Song Y, Wang H. Systematic elucidation of the aneuploidy landscape and identification of aneuploidy driver genes in prostate cancer. Front Cell Dev Biol. 2022;9:723466.","DOI":"10.3389\/fcell.2021.723466"},{"key":"3203_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"S-K Seo","year":"2023","unstructured":"Seo S-K, Kwon B. Immune regulation through tryptophan metabolism. Exp Mol Med. 2023;55:1371\u20139.","journal-title":"Exp Mol Med"},{"key":"3203_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.20892\/j.issn.2095-3941.2020.0617","volume":"18","author":"D Drago","year":"2021","unstructured":"Drago D, Andolfo A, Mosca E, Orro A, Nocera L, Cucchiara V, et al. A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer. Cancer Biol Med. 2021;18:604\u201315.","journal-title":"Cancer Biol Med"},{"key":"3203_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s42003-025-07984-2","volume":"8","author":"S Zhu","year":"2025","unstructured":"Zhu S, Zhang R, Yao L, Lin Z, Li Y, Li S, et al. De novo NAD+ synthesis is ineffective for NAD+ supply in axenically cultured Caenorhabditis elegans. Commun Biol. 2025;8:545.","journal-title":"Commun Biol"},{"key":"3203_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37170-z","volume":"14","author":"P Kesarwani","year":"2023","unstructured":"Kesarwani P, Kant S, Zhao Y, Prabhu A, Buelow KL, Miller CR, et al. Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR\/PPAR\u03b3 signaling axis. Nat Commun. 2023;14:1459.","journal-title":"Nat Commun"},{"key":"3203_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3203_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"3203_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"3203_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol. 2021;39:599\u2013608.","journal-title":"Nat Biotechnol"},{"key":"3203_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"3203_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"3203_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. 2012;16:284\u20137.","journal-title":"OMICS J Integr Biol"},{"key":"3203_CR28","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1038\/onc.2014.401","volume":"34","author":"L Wang","year":"2015","unstructured":"Wang L, Song G, Chang X, Tan W, Pan J, Zhu X, et al. The role of TXNDC5 in castration-resistant prostate cancer\u2014involvement of androgen receptor signaling pathway. Oncogene. 2015;34:4735\u201345.","journal-title":"Oncogene"},{"key":"3203_CR29","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA. 2009;106:21984\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3203_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature13181","volume":"508","author":"H Gad","year":"2014","unstructured":"Gad H, Koolmeister T, Jemth A-S, Eshtad S, Jacques SA, Str\u00f6m CE, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 2014;508:215\u201321.","journal-title":"Nature"},{"key":"3203_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong B, Miao J, Wang Y, Luo W, Ji Z, Lai H, et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun Biol. 2020;3:778.","journal-title":"Commun Biol"},{"key":"3203_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao Y-T, Zhang N, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23:87\u201398.","journal-title":"Nat Cell Biol"},{"key":"3203_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01264-9","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, Guo J, Liu K, Chen L, Liu D, Dong S, et al. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Mol Cancer. 2020;19:147.","journal-title":"Mol Cancer"},{"key":"3203_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01597-7","volume":"21","author":"I Heidegger","year":"2022","unstructured":"Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, et al. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Mol Cancer. 2022;21:132.","journal-title":"Mol Cancer"},{"key":"3203_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322203121","volume":"121","author":"S Zaidi","year":"2024","unstructured":"Zaidi S, Park J, Chan JM, Roudier MP, Zhao JL, Gopalan A, et al. Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies. Proc Natl Acad Sci USA. 2024;121:e2322203121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3203_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun. 2022;13:141.","journal-title":"Nat Commun"},{"key":"3203_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104576","volume":"25","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang T, Hong D, Dong B, Wang Y, Huang H, et al. Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer. iScience. 2022;25:104576.","journal-title":"iScience"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03203-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:09:23Z","timestamp":1787612963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3203"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03203-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"344"}}